{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:33:19Z","timestamp":1759411999541},"reference-count":47,"publisher":"Infectious Disease and Control Branch (IDPCB) - Public Health Agency of Canada","issue":"ACS-3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.14745\/ccdr.v39i00a03","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T20:19:36Z","timestamp":1519849176000},"page":"1-52","source":"Crossref","is-referenced-by-count":12,"title":["GUIDELINES FOR THE PREVENTION AND CONTROL OF MEASLES OUTBREAKS IN CANADA"],"prefix":"10.14745","volume":"39","member":"5795","published-online":{"date-parts":[[2013,10]]},"reference":[{"key":"key20180228151919_r1"},{"key":"key20180228151919_r2","article-title":"Statement on Measles-Mumps-Rubella-Varicella Vaccine","volume":"36","author":"National Advisory Committee on Immunization (NACI)","year":"2010","journal-title":"Can Commun Dis Rep"},{"key":"key20180228151919_r3"},{"issue":"10","key":"key20180228151919_r4","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/644783","article-title":"Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons","volume":"200","year":"2009","journal-title":"J Infect Dis"},{"key":"key20180228151919_r5","unstructured":"Pan-American Health Organization (PAHO). Measles elimination field guide. 2005; Available at: www1.paho.org\/english\/ad\/fch\/im\/fieldguide_measles.pdf"},{"key":"key20180228151919_r6","article-title":"Case definitions for diseases under national surveillance","volume":"35","author":"Public Health Agency of Canada","year":"2009","journal-title":"Can Commun Dis Rep"},{"key":"key20180228151919_r7","unstructured":"World Health Organization. World Health Organization. Measles fact sheet N\u00b0286. 2012; Available at: www.who.int\/mediacentre\/factsheets\/fs286\/en. Accessed October, 2011."},{"key":"key20180228151919_r8"},{"key":"key20180228151919_r9","unstructured":"Public Health Agency of Canada. What you need to know about measles. 2011; Available at: www.phac-aspc.gc.ca\/im\/iyc-vve\/faq-dis-mal\/measles-rougeole-eng.php. Accessed November 9, 2011."},{"issue":"6","key":"key20180228151919_r10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/CDLI.6.6.868-871.1999","article-title":"Decay of passively acquired maternal antibodies against measles, mumps, and rubella viruses","volume":"6","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"key20180228151919_r11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/01443610903104478","article-title":"The rationale for the use of measles post-exposure prophylaxis in pregnant women: a review","volume":"29","year":"2009","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"key20180228151919_r12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/clinids\/14.1.217","article-title":"Complications of measles during pregnancy","volume":"14","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"3","key":"key20180228151919_r13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1526-0542(03)00061-7","article-title":"Respiratory virus infections in the immunocompromised host","volume":"4","year":"2003","journal-title":"Paediatr Respir Rev"},{"key":"key20180228151919_r14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0002-9343(97)00003-X","article-title":"Respiratory viral infections in immunocompetent and immunocompromised persons","volume":"102","year":"1997","journal-title":"Am J Med"},{"key":"key20180228151919_r15","unstructured":"National Advisory Committee on Immunization (NACI). Canadian immunization guide. Part 4: Active Vaccines\u2014Measles Vaccine. 2012; Available at: www.phac-aspc.gc.ca\/publicat\/cig-gci\/p04-meas-roug-eng.php. Accessed December, 2012."},{"key":"key20180228151919_r16"},{"issue":"1","key":"key20180228151919_r17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.aje.a115106","article-title":"An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"issue":"10","key":"key20180228151919_r18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.1986.03370100089023","article-title":"Transmission of measles in medical settings. 1980 through 1984","volume":"255","year":"1986","journal-title":"JAMA"},{"issue":"3","key":"key20180228151919_r19","first-page":"415","article-title":"Measles transmission in medical facilities","volume":"142","year":"1985","journal-title":"West J Med"},{"issue":"11","key":"key20180228151919_r20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.1985.03350350068022","article-title":"Airborne transmission of measles in a physician\u2019s office","volume":"253","year":"1985","journal-title":"JAMA"},{"issue":"4","key":"key20180228151919_r21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1542\/peds.75.4.676","article-title":"Measles outbreak in a pediatric practice: airborne transmission in an office setting","volume":"75","year":"1985","journal-title":"Pediatrics"},{"issue":"3","key":"key20180228151919_r22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1542\/peds.79.3.356","article-title":"Measles spread in medical settings: an important focus of disease transmission?","volume":"79","year":"1987","journal-title":"Pediatrics"},{"issue":"9","key":"key20180228151919_r23","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2105\/AJPH.77.9.1222","article-title":"A measles outbreak at university medical settings involving health care providers","volume":"77","year":"1987","journal-title":"Am J Public Health"},{"issue":"5","key":"key20180228151919_r24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0196-6553(87)90096-4","article-title":"Measles (rubeola) infection in a hospital setting","volume":"15","year":"1987","journal-title":"Am J Infect Control"},{"issue":"4","key":"key20180228151919_r25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2307\/30144322","article-title":"The importance of nosocomial transmission of measles in the propagation of a community outbreak","volume":"10","year":"1989","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"key20180228151919_r26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0196-6553(05)80236-6","article-title":"Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989","volume":"20","year":"1992","journal-title":"Am J Infect Control"},{"issue":"1","key":"key20180228151919_r27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2307\/30148377","article-title":"Measles and healthcare workers","volume":"15","year":"1994","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"key20180228151919_r28","first-page":"1","article-title":"Measles among healthcare workers: a potential for nosocomial outbreaks","volume":"16","year":"2011","journal-title":"Euro Surveill"},{"key":"key20180228151919_r29","first-page":"S1","article-title":"Infection control guidelines: prevention and control of occupational infections in health care","volume":"28","author":"Public Health Agency of Canada","year":"2002","journal-title":"Can Commun Dis Rep"},{"key":"key20180228151919_r30"},{"key":"key20180228151919_r31"},{"issue":"1","key":"key20180228151919_r32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/rmv.1980050105","article-title":"The contribution of field tests to measles surveillance and control: A review of available methods","volume":"5","year":"1995","journal-title":"Medical Virology"},{"key":"key20180228151919_r33"},{"key":"key20180228151919_r34"},{"key":"key20180228151919_r35","first-page":"183","article-title":"Detection of measles, mumps, and rubella viruses","volume":"665","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key20180228151919_r36","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1093\/infdis\/jir106","article-title":"Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"key":"key20180228151919_r37","doi-asserted-by":"crossref","first-page":"S559","DOI":"10.1093\/infdis\/jir098","article-title":"Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: high risk of infection but low risk of transmission","volume":"204","year":"2011","journal-title":"J Infect Dis"},{"issue":"1","key":"key20180228151919_r38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"WHO working group on measles plaque reduction neutralization test","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"key20180228151919_r39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM199003013220903","article-title":"Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines","volume":"322","year":"1990","journal-title":"N Engl J Med"},{"issue":"5","key":"key20180228151919_r40","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","year":"1990","journal-title":"J Infect Dis"},{"issue":"1","key":"key20180228151919_r41","first-page":"1","article-title":"Flu shots, mammograms and the perception of probabilities","volume":"5739","year":"2011","journal-title":"IZA Discussion Papers"},{"issue":"2","key":"key20180228151919_r42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ypmed.2010.11.010","article-title":"The public\u2019s preventive strategies in response to the pandemic influenza A\/H1N1 in France: distribution and determinants","volume":"52","year":"2011","journal-title":"Prev Med"},{"issue":"2","key":"key20180228151919_r43","first-page":"1","article-title":"Meeting of the panel of experts for the documentation and verification of measles, rubellal, and CRS elimination","volume":"31","author":"Pan American Health Organization (PAHO)","year":"2009","journal-title":"Immunization Newsletter"},{"issue":"11","key":"key20180228151919_r44","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1016\/j.ijid.2010.06.009","article-title":"Oral fluid for the serological and molecular diagnosis of measles","volume":"14","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"916","key":"key20180228151919_r45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/pmj.78.916.63","article-title":"Subacute sclerosing panencephalitis","volume":"78","year":"2002","journal-title":"Postgrad Med J"},{"issue":"1-2","key":"key20180228151919_r46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2005.10.006","article-title":"Development of quantitative gene-specific real-time RT-PCR assays for the detection of measles virus in clinical specimens","volume":"132","year":"2006","journal-title":"J Virol Methods"},{"issue":"35","key":"key20180228151919_r47","first-page":"265","article-title":"Expanded Programme on Immunization (EPI). Standardization of the nomenclature for describing the genetic characteristics of wild-type measles viruses","volume":"73","author":"Expanded Programme on Immunization (EPI)","year":"1998","journal-title":"Wkly Epidemiol Rec"}],"container-title":["Canada Communicable Disease Report"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-3\/assets\/pdf\/meas-roug-eng.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T01:29:35Z","timestamp":1660526975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.canada.ca\/content\/dam\/phac-aspc\/migration\/phac-aspc\/publicat\/ccdr-rmtc\/13vol39\/acs-dcc-3\/assets\/pdf\/meas-roug-eng.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":47,"journal-issue":{"issue":"ACS-3","published-online":{"date-parts":[[2013,10]]},"published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.14745\/ccdr.v39i00a03","relation":{},"ISSN":["1481-8531"],"issn-type":[{"value":"1481-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}